|Dr. Chi-Keon Loh||MD, CEO & Exec. Director||N/A||N/A||1974|
|Mr. Soon Teck Low||Group Chief Financial Officer||N/A||N/A||1965|
|Prof. Heng Joo Sim||Group Chief Operating Officer||N/A||N/A||1972|
|Ms. Penelope Koh||VP of Investor Relations||N/A||N/A||N/A|
|Ms. Ida Suryati Binti Ab Rahim||Group Gen. Counsel & Company Sec.||N/A||N/A||1973|
IHH Healthcare Berhad, an investment holding company, provides healthcare services. It provides primary care services, such as treatment of basic illnesses, routine check-ups, and vaccinations. The company also offers secondary services, including specialist consultation, local surgeries, emergency care, laboratory, diagnostics, and acute treatment services; tertiary care services comprising specialist consultative care, advanced treatment or complex surgery, and inpatient care services; and quaternary care services consisting of complex surgeries, such as, organ transplants, neurosurgery, cardiac surgery, and reconstructive plastic surgery. In addition, it provides a range of ancillary services, including diagnostics, analytical laboratory testing, therapeutic radiology, physiotherapy, and integrated rehabilitation and advanced molecular diagnostics services. Further, the company offers medical education and real estate investment trust services. It operated approximately 15,000 licensed beds across 77 hospitals in 10 countries worldwide. The company was formerly known as Integrated Healthcare Holdings Berhad and changed its name to IHH Healthcare Berhad in April 2012. IHH Healthcare Berhad was incorporated in 2010 and is based in Kuala Lumpur, Malaysia.
IHH Healthcare Berhad’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.